Purpose

Revolutionizing Drug Development with AI

Transforming Drug Discovery with Proven Success

Our unique AI-driven platform has already yielded tangible results with

16

New chemical entities designed by EvoFoundry, including 1 preparing to enter Phase 3, and 1 preparing to enter clinical trial phase 2.

 Reaching Where Medicines Struggle to Go 

We focus on oncology, immune-mediated and central nervous system diseases. The blood-brain barrier protects the brain, but it also keeps most drugs out — one reason cancers that spread to the brain, and many neurological conditions, remain so difficult to treat. AccSalus designs brain penetration into its molecules from the very first step, rather than attempting to add it later. 

Focused on oncology, autoimmune disorders, and central nervous system diseases,

We’re developing precision therapies that target the most challenging conditions, delivering hope to those who need it most.